发明名称 Substituted azabicyclic compounds
摘要 This invention is directed to physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; and N-oxides thereof, and pharmaceutically acceptable salts of the compounds of formula (I) and N-oxides thereof, Such compounds inhibit the production or physiological effects of TNF and inhibit cyclic AMP phosphodiesterase. The invention is also directed to pharmnaceutical compositions comprising compoundS of formula (I), their phatmaceUtical use and methods for their preparation.
申请公布号 US7329675(B2) 申请公布日期 2008.02.12
申请号 US20040933077 申请日期 2004.09.01
申请人 AVENTIS PHARMA LIMITED 发明人 COX PAUL JOSEPH;BOWER SHELLEY;ALDOUS DAVID JOHN;ASTLES PETER CHARLES;MCGARRY DANIEL GERARD;HULME CHRISTOPHER;REGAN JOHN ROBINSON;HUANG FU-CHIH;DJURIC STEVAN WAKEFIELD;MORIARTY KEVIN JOSEPH;MATHEW ROSE MAPPILAKUNNEL;POLI GREGORY BERNARD
分类号 A61K31/44;C07D235/08;A61K31/00;A61K31/40;A61K31/403;A61K31/404;A61K31/41;A61K31/415;A61K31/4164;A61K31/4184;A61K31/4196;A61K31/42;A61K31/422;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/47;A61K31/4709;A61K31/496;A61K31/505;A61K31/506;A61K31/535;A61K31/5355;A61K31/5375;A61K31/5377;A61P9/00;A61P11/00;A61P17/00;A61P25/04;A61P29/00;A61P35/00;A61P37/00;A61P43/00;C07D209/08;C07D209/12;C07D209/42;C07D235/12;C07D235/24;C07D401/06;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D405/00;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/14 主分类号 A61K31/44
代理机构 代理人
主权项
地址